Replimune Group, Inc.
US ˙ NasdaqGS ˙ US76029N1063

SecurityREPL / Replimune Group, Inc.
InstitutionQube Research & Technologies Ltd
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Qube Research & Technologies Ltd closes position in REPL / Replimune Group, Inc.

On November 14, 2025 - Qube Research & Technologies Ltd filed a 13F-HR form disclosing ownership of 0 shares of Replimune Group, Inc. (US:REPL) valued at $0 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 14, 2025 disclosing 53,805 shares of Replimune Group, Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-11-14 2025-09-30 13F REPLIMUNE GROUP COM 76029N106 0 -100.00 0
2025-08-14 2025-06-30 13F REPLIMUNE GROUP COM 76029N106 53,805 1,025 1.94 500 -2.92 0.0005
2025-05-15 2025-03-31 13F REPLIMUNE GROUP COM 76029N106 52,780 52,780 515 0.0006
2024-08-14 2024-06-30 13F REPLIMUNE GROUP COM 76029N106 0 -221,222 -100.00 0 -100.00
2024-05-14 2024-03-31 13F REPLIMUNE GROUP COM 76029N106 221,222 -173,494 -43.95 1,807 -45.69 0.0029
2024-02-13 2023-12-31 13F REPLIMUNE GROUP COM 76029N106 394,716 394,716 3,327 0.0065
2023-08-14 2023-06-30 13F REPLIMUNE GROUP COM 76029N106 0 -99,182 -100.00 0 -100.00
2023-05-15 2023-03-31 13F REPLIMUNE GROUP COM 76029N106 99,182 99,182 1,752 0.0075
2022-08-15 2022-06-30 13F REPLIMUNE GROUP COM 76029N106 0 -49,090 -100.00 0 -100.00
2022-05-09 2022-03-31 13F REPLIMUNE GROUP COM 76029N106 49,090 49,090 834 0.0071
2022-02-10 2021-12-31 13F/A-1 REPLIMUNE GROUP COM 76029N106 0 -7,131 -100.00 0 -100.00
2022-02-01 2021-12-31 13F REPLIMUNE GROUP COM 76029N106 0 -7,131 0
2021-11-12 2021-09-30 13F REPLIMUNE GROUP COM 76029N106 7,131 7,131 211 0.0026
2021-08-13 2021-06-30 13F REPLIMUNE GROUP COM 76029N106 0 -12,819 -100.00 0 -100.00
2021-05-14 2021-03-31 13F REPLIMUNE GROUP COM 76029N106 12,819 12,819 391 0.0062
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.